Economics
Theranos Hires Compliance, Quality Chiefs in Effort to Reform
- Attorney Guggenheim joins struggling startup from McKesson
- Wurtz leaves Thermo Fisher to oversee testing labs’ quality
This article is for subscribers only.
Embattled blood-testing startup Theranos Inc. hired two executives to oversee regulatory, quality and compliance standards as the company seeks to reform itself after receiving heavy sanctions from U.S. regulators.
Dave Wurtz, who formerly worked at Thermo Fisher Scientific Inc., was named vice president, regulatory and quality, and will oversee standards for laboratories and device development. Daniel Guggenheim, who previously served as assistant general counsel at McKesson Corp., will be chief compliance officer, charged with making sure the startup follows federal and state health regulations, board member Fabrizio Bonanni said in a telephone interview.